Cargando…
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer
It has recently been suggested that the chemokine receptor (CCR5) is required for bone marrow (BM) derived endothelial progenitor cell (EPC) mediated angiogenesis. Here we show that suppression of either cancer cell produced CCL5, or host CCR5 leads to distinctive vascular and tumor growth defects i...
Autores principales: | Sax, Michael John, Gasch, Christin, Athota, Vineel Rag, Freeman, Ruth, Rasighaemi, Parisa, Westcott, David Elton, Day, Christopher John, Nikolic, Iva, Elsworth, Benjamin, Wei, Ming, Rogers, Kelly, Swarbrick, Alexander, Mittal, Vivek, Pouliot, Normand, Mellick, Albert Sleiman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356747/ https://www.ncbi.nlm.nih.gov/pubmed/27863423 http://dx.doi.org/10.18632/oncotarget.13387 |
Ejemplares similares
-
Discovering cancer vulnerabilities using high-throughput micro-RNA screening
por: Nikolic, Iva, et al.
Publicado: (2017) -
Zebrafish as a model for leukemia and other hematopoietic disorders
por: Rasighaemi, Parisa, et al.
Publicado: (2015) -
CCL21 Cancer Immunotherapy
por: Lin, Yuan, et al.
Publicado: (2014) -
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
por: Lin, Hui-Ming, et al.
Publicado: (2018) -
CCL18 in the Progression of Cancer
por: Korbecki, Jan, et al.
Publicado: (2020)